Cargando…

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs

Nonsteroidal anti-inflammatory drugs (NSAIDs) are highly effective in treating the pain and inflammation associated with osteoarthritis and rheumatoid arthritis, but it is well recognized that these agents are associated with substantial gastrointestinal toxicity. Treatment guidelines suggest that p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheiman, James M, Fendrick, A Mark
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833978/ https://www.ncbi.nlm.nih.gov/pubmed/16168078 http://dx.doi.org/10.1186/ar1795

Ejemplares similares

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage
por: Scheiman, James M
Publicado: (2013)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Relative Value of the NSAIDs, Including COX-2 Inhibitors and Meloxicam
por: Curtiss, Frederic R.
Publicado: (2006)

Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs
por: Stockl, Karen, et al.
Publicado: (2005)

Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury
por: Yang, Man, et al.
Publicado: (2015)

Review of the cardiovascular safety of COXIBs compared to NSAIDS
por: Moodley, I
Publicado: (2008)

Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2017)

Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
por: Thalappil, Sherin, et al.
Publicado: (2022)

Prescription Pattern of NSAIDs and the Prevalence of NSAID-induced Gastrointestinal Risk Factors of Orthopaedic Patients in Clinical Practice in Korea
por: Lee, Sung-Hun, et al.
Publicado: (2011)

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
por: Bokhtia, Riham M., et al.
Publicado: (2023)

Cardiovascular Risk of NSAIDs: Time to Translate Knowledge into Practice
por: Reddy, K. Srinath, et al.
Publicado: (2013)

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
por: Cheng, I, et al.
Publicado: (2007)

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
por: Kim, Jungmee, et al.
Publicado: (2015)

NSAIDs and self-medication: A serious concern
por: Doomra, Reena, et al.
Publicado: (2020)

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
por: Latimer, Nicholas, et al.
Publicado: (2009)

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
por: Parkinson, Lynne, et al.
Publicado: (2011)

COX-2: Where are we in 2003? - Distinction from NSAIDs becoming blurred
por: Day, Richard
Publicado: (2003)

Colonic Mass After NSAID Use and Concerns for Malignancy
por: Ho, Kimberly, et al.
Publicado: (2023)

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs
por: Peura, David A, et al.
Publicado: (2005)

Management of NSAID Associated Upper Gastrointestinal Problems
por: Cryer, Byron
Publicado: (2005)

Treatment and chemoprevention of NSAID-associated gastrointestinal complications
por: Frech, Edward J, et al.
Publicado: (2009)

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
por: McEvoy, L., et al.
Publicado: (2021)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

The importance of provocation tests with COX2 inhibitors on patients with a history of cross-hypersensitivity to non-steroidal anti-inflammatory (NSAIDs)
por: Gonçalves, Tania Tavares
Publicado: (2015)

Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis
por: Lanas, Angel, et al.
Publicado: (2011)

Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review
por: Sohail, Rohab, et al.
Publicado: (2023)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Moore, R Andrew, et al.
Publicado: (2006)

Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses
por: Datto, Catherine, et al.
Publicado: (2013)

COX-2 inhibitory NSAID-induced multiple stenosis in the small intestine diagnosed by double-balloon endoscopy
por: Ueno, Yasuaki, et al.
Publicado: (2016)

Practical Approach to Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Children
por: Podlecka, Daniela, et al.
Publicado: (2023)

Assessment of Qatar community pharmacists’ competence and practices related to renal and gastrointestinal adverse effects of nonprescription NSAIDs
por: Owusu, Yaw Boahene, et al.
Publicado: (2022)

Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials
por: Goldstein, J L, et al.
Publicado: (2011)

NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species
por: Ghosh, Rajeshwary, et al.
Publicado: (2015)

Balancing gastrointestinal benefit–risk in individuals who are prescribed NSAIDs for arthritis
por: Bijlsma, Johannes W. J.
Publicado: (2010)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009)

Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal Defence
por: Blackler, Rory, et al.
Publicado: (2012)

Review of gastrointestinal bleeding during use of SSRIs combined with use of NSAID
por: Arts, M., et al.
Publicado: (2022)

Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
por: Gao, Feng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2q5745jkhjif7ubbfgu2l1nu84